ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer enabled therapeutics firstwordpharma
July 23, 2021Aptamer Group, the developer of Optimer? therapeutics and diagnostics, and WuXi AppTec Research Service Division, an integrated chemistry and biology research platform, today announce a research collaboration to identify new Optimer?-enabled therapeutics. -
Aptamer Group: UK Biotech Business Raises $2.2M Investment
b3cnewswire
July 24, 2018Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme. -
Aptamer Group: UK Biotech Business Raises $2.2M Investment
b3cnewswire
July 04, 2018Rapidly growing biotech business,?Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors to support its pioneering aptamer development programme.
Pharma Sources Insight January 2025
